These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-002811-98 Randomised phase II study of cetuximab in combination with gemcitabine or gemcitabine followed by cetuximab in patients with advanced non-small-cell lung cancer, not suitable for standard platin-based... not-yet-due
Listed as ongoing, but also has a completion date 2004-004456-39 A Multi-National, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients with Epithelial Ovarian Ca... 2012-06-01 bad-data
Completed, but no date Terminated 2005-005631-97 None bad-data
Ongoing 2005-005968-90 An international multicenter randomized phase III study of first-line Erlotinib followed by second-line Cisplatin Gemcitabine versus first-line Cisplatin Gemcitabine followed by second-line Erlot... not-yet-due
Exempt 2006-000426-31 STUDIO DI FASE I DELLA COMBINAZIONE FARMACOLOGICA TRA ACIDO ZOLEDRONICO E DOCETAXEL IN PAZIENTI CON CARCINOMA PROSTATICO METASTATICO ORMONO - REFRATTARIO not-yet-due
Ongoing 2006-001724-40 Phase II study with capecitabine as monotherapy in the treatment of platinum resistant or refractory ovarian cancer not-yet-due
Ongoing 2006-003243-23 A Phase II Study of OXALIPLATIN and GEMCITABINE in Combination with IFOSFAMIDE plus RITUXIMAB (R-GIFOX) as 2nd-line Chemotherapy in Relapsed and Primary Refractory Lymphoma not-yet-due
Completed, but no date Terminated 2006-003993-85 Phase II Study of neoadjuvant therapy with trastuzumab plus docetaxel followed by trastuzumab plus pegylated liposomal doxorubicin and cyclophosphamide in human ErbB-2-positive operable or locally adv... bad-data
Ongoing 2006-003994-28 VINORELBINE, CARBOPLATIN AND TRASTUZUMAB IN ADVANCED HER-2 POSITIVE BREAST CANCER. A PHASE 2 STUDY not-yet-due
Completed, but no date 2006-003995-36 A MULTICENTER RANDOMIZED PHASE III STUDY COMPARING FIXED DOSES WITH TOXICITY-ADJUSTED DOSES OF STANDARD CHEMOTHERAPY WITH CISPLATIN AND ETOPOSIDE IN PATIENTS AFFECTED BY ADVANCED SMALL CELL LUNG CANCE... bad-data
Ongoing 2008-001754-40 WEEKLY vs EVERY 3 WEEK CARBOPLATIN + PACLITAXEL IN PATIENTS WITH OVARIAN CANCER: RANDOMIZED MULTICENTER STUDY not-yet-due
Ongoing 2008-001755-22 STEALTH LIPOSOMAL DOXORUBICIN vs CARBOPLATIN/PACLITAXEL IN PATIENTS WITH OVARIAN CANCER RECURRENCE BETWEEN SIX AND TWELVE MONTHS AFTER PREVIOUS PLATINUM BASED CHEMOTHERAPY: PHASE III MULTICENTER RANDO... not-yet-due
Completed, but no date 2008-005307-26 Intratecal Ziconotide in the treatment of neuropatic pain in cancer patients. A phase II study. bad-data
Ongoing 2009-010099-74 A RANDOMIZED PHASE II STUDY OF CARBOPLATIN AND PACLITAXEL +/- CETUXIMAB, IN ADVANCED AND/OR RECURRENT CERVICAL CANCER not-yet-due
Ongoing 2009-013540-36 The MILES-3 randomized phase III study assessing the efficacy of cisplatin combined with gemcitabine as first-line therapy of elderly patients with advanced non small cell lung cancer. not-yet-due
Ongoing 2009-013870-42 Sorafenib in the first line treatment of advanced hepatocellular carcinoma with ChildPugh liver function class B. Multicentre phase 3 randomized trial not-yet-due
Completed, but no date 2009-016151-21 A randomized multicentre phase II trial with pazopanib and weekly paclitaxel vs weekly paclitaxel in platinum resistant or refractory ovarian cancer bad-data
Ongoing 2010-018363-42 A phase II dose finding study of induction cisplatin, docetaxel and escalating doses of capecitabine followed by concurrent cetuximab and radiotherapy in locally advanced inoperable head and neck squa... not-yet-due
Ongoing 2010-018581-23 CONSERVATIVE MANAGEMENT OF ENDOMETRIAL CANCER AND ATYPICAL HYPERPLASIA not-yet-due
Ongoing 2010-024490-39 A phase 2 study of panitumumab in patients with cetuximab-refractory metastatic colorectal cancer not-yet-due
Ongoing 2011-000587-10 SODIUM PICOSULPHATE AND MAGNESIUM CITRATE VERSUS POLYETHYLENE GLYCOLE (PEG) AS EVACUATING TREATMENT PRIOR TO COLONOSCOPY: PHASE IV RANDOMIZED TRIAL not-yet-due
Ongoing 2011-001739-21 A study of Sativex for pain Relief and appetite stimulation in Patients with advanced malignancy. Phase II Studio monocentrico di fase II per la valutazione degli effetti clinici ed immunologici de... not-yet-due
Ongoing 2011-002810-35 A Phase 1/2 Study of Lenalidomide in combination with Bendamustine (LEBEN) in relapsed and primary refractory Hodgkin Lymphoma Studio di Fase 1/2 sull'utilizzo di Lenalidomide in combinazione con... not-yet-due
Ongoing 2011-004997-27 Randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer Studio randomizzato di fase III sull'... not-yet-due
Completed, but no date Terminated 2011-006097-76 RANDOMIZED PHASE 3 TRIAL EVALUATING THE EFFICACY OF LOCOREGIONAL TREATMENT WITH TRANSARTERIAL EMBOLIZATION (TAE) FOR LIVER METASTASIS, IN COMBINATION WITH OCTREOTIDE LAR, IN PATIENTS WITH NEUROENDOCRI... bad-data
Ongoing 2012-000164-25 A factorial study comparing pemetrexed with gemcitabine and testing the efficacy of the addition of cisplatin in elderly patients with non squamous advanced, metastatic or recurrent NSCLC. Studio m... not-yet-due
Ongoing 2012-003043-29 A multicenter study in patients with stage III-IV epithelial ovarian cancer treated with carboplatin/paclitaxel with bevacizumab: clinical and biological prognostic factors Studio multicentrico in ... not-yet-due
Listed as ongoing, but also has a completion date 2012-004362-17 A multicenter phase III randomized study with second line chemotherapy plus or minus bevacizumab in patients with platinum sensitive epithelial ovarian cancer recurrence after a bevacizumab/chemothera... 2018-01-08 bad-data
Completed, but no date Terminated 2013-001630-18 Multicentre phase 2 study of neoadjuvant oxaliplatin and capecitabine followed by chemo-radiotherapy in patients with locally advanced carcinoma of esphago-gastric junction. Studio multicentrico ... bad-data
Completed, but no date Terminated 2013-002074-46 Multicentre, two-stage, phase 2 study of neoadjuvant FOLFIRINOX followed by chemo-IMRT in patients with locally advanced unresectable pancreatic cancer Studio multicentrico di fase II, di chemioter... bad-data
Ongoing 2014-001523-69 Preclinical and clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of head and neck not-yet-due
Ongoing 2015-001105-13 Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer: a multicentre, single-arm, two-stage, phase 2 study. Regorafenib monotherapy as second-line ... not-yet-due
Ongoing 2015-002235-17 A randomized open-label phase 3 trial comparing bevacizumab + erlotinib vs erlotinib alone as first line treatment of patients with EGFR mutated advanced non squamous non small cell lung cancer. A ... not-yet-due
Exempt, with results 2015-003389-10 A phase I/II trial of IMA970A plus CV8102 following a single pre-vaccination infusion of cyclophosphamide in patients with very early, early and intermediate stage of hepatocellular carcinoma after an... 2019-12-20 not-yet-due
Ongoing 2015-005147-14 The effect of low dietary glycemic index, excercise and vitamin D on breast cancer recurrence in women L¿effetto della combinazione di dieta a basso indice glicemico, esercizio fisico e vitamina D ... not-yet-due
Ongoing 2016-001296-67 DUAL ENERGY CONTRAST ENHANCED DIGITAL MAMMOGRAPHY PERFORMANCE EVALUATION IN COMPARISON OF CONVENTIONAL DIGITAL MAMMOGRAPHY, TOMOSINTESIS AND MR IMAGING IN WOMEN FOLLOW-UP FOR BREAST CARCINOMA VAL... not-yet-due
Other 2016-002286-60 A PHASE II/III RANDOMIZED STUDY OF PEMBROLIZUMAB IN PATIENTS WITH ADVANCED MALIGNANT PLEURAL MESOTHELIOMA not-yet-due
Ongoing 2016-003926-18 A phase II clinical trial of Pembrolizumab in combination with Carboplatin-Paclitaxel in patients with advanced (stage III B-C-IV) ovarian, primary peritoneal and fallopian tube cancer: MITO28/MANGO O... not-yet-due
Ongoing 2016-005238-31 A Phase II Single Arm Trial Evaluating the Efficacy and Safety of Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas Progressing after First-Line Platinum- based Therapy Studio di ... not-yet-due
Completed, but no date 2017-001613-83 Octreotide LAR in the induction of immunologic response in patient with neuroendocrine tumors: an interventional pharmacological study Valutazione del ruolo dell¿Octreotide LAR nell¿immunomodulazi... bad-data
Ongoing 2017-001664-37 A randomized phase 2 study comparing immunotherapy with chemotherapy in the treatment of elderly patients with advanced NSCLC MILES 5 – A randomized phase 2 study comparing immunotherapy with chemo... not-yet-due
Ongoing 2017-003628-65 Intermittent or continuous Panitumumab plus FOLFIRI for first-line treatment of patients with RAS/B-RAF wild-type metastatic colorectal cancer: a randomized phase 2 trial Intermittent or continuous... not-yet-due
Ongoing 2017-004213-24 A RANDOMIZED TRIAL OF DURVALUMAB AND TREMELIMUMAB ¿ PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH HIGH-RISK, METASTATIC (STAGE IV) SQUAMOUS OR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) A RANDO... not-yet-due
Ongoing 2018-000617-20 A phase II trial of Olaparib in patients with recurrent ovarian cancer wild type for germline and somatic BRCA 1 and 2 genes: The MITO 31 transalational study. Studio clinico di fase 2 di Olaparib ... not-yet-due
Ongoing 2018-003531-30 Electrochemotherapy versus narrow excision margins for high-risk, primary cutaneous melanoma Elettrochemioterapia versus escissione chirurgica con margini stretti nel melanoma cutaneo primario ad a... not-yet-due
Ongoing 2018-003589-15 Electrochemotherapy as a first line treatment in recurrent squamous cell carcinoma of the oral cavity and oropharynx: a randomized controlled trial Elettrochemioterapia come trattamento di prima li... not-yet-due
Ongoing 2018-003778-29 Phase II study on the use of the FOLFIRI + Cetuximab association in the first-line treatment of patients with advanced colorectal carcinoma with wild type RAS and FcYRIIIA-V / V Studio di fase II s... not-yet-due
Ongoing 2018-003925-27 Prospective phase IIb study to evaluate the efficacy of laparoscopic electrochemotherapy in the treatment of locally advanced pancreatic cancer Studio prospettico di fase IIb per valutare l’efficac... not-yet-due
Ongoing 2018-004166-33 ORGAN SPARING FOR LOCALLY ADVANCED RECTAL CANCER AFTER NEOADJUVANT TREATMENT FOLLOWED BY ELECTROCHEMOTHERAPY ORGAN SPARING FOR LOCALLY ADVANCED RECTAL CANCER AFTER NEOADJUVANT TREATMENT FOLLOWED BY... not-yet-due
Ongoing 2018-004385-34 Neoadjuvant Aspirin and/or Metformin during preoperative induction chemotherapy and chemoradiotherapy for locally-advanced rectal cancer. A multi-arm, multi-stage, intergroup (STAR-04/SICO-CR01/GISCAD... not-yet-due
Ongoing 2019-003699-38 DETECTION RATE AND CLASSIFICATION OF BREAST LESIONS WITH DIGITAL MAMMOGRAPHY WITH CONTRAST MEDIUM (CEDM) ALONE AND IN COMBINATION WITH TOMOSYNTHESIS COMPARED TO MR IMAGING WITH GADOLINIUM IN DYNAMICS ... not-yet-due
Ongoing 2020-001110-38 Multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia Multicenter study on the efficacy and tolerability of tocilizumab in the treat... not-yet-due
Ongoing 2020-001898-78 A Phase II Single Arm Interventional Trial Evaluating the Activity and Safety of combination between Cabozantinib and Temozolomide in Lung and GEP-NENs progressive after SSAr, everolimus, sunitinib or... not-yet-due
Ongoing 2021-000244-21 MITO 35a: a multicenter, prospective, single arm trial of Olaparib maintenance therapy in newly diagnosed BRCA wild-type advanced ovarian, fallopian tube and primitive peritoneal cancer. Mito 35a -... not-yet-due
Ongoing 2021-000245-41 Olaparib beyond progression compared to platinum chemotherapy after secondary cytoreductive surgery in recurrent ovarian cancer patients. The phase III randomized, open label MITO 35b study: a project... not-yet-due
Ongoing 2021-000458-24 Pilot study on electrochemotherapy in metastatic breast cancer (BREAST ECT) Studio pilota su elettrochemioterapia nel cancro della mammella metastatico (BREAST ECT) not-yet-due